[Federal Register Volume 61, Number 24 (Monday, February 5, 1996)]
[Notices]
[Page 4289]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-2315]



-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated August 21, 1995, and published in the Federal 
Register on August 30, 1995, (60 FR 45169), Celgene Corporation, 7 
Powder Horn Drive, Warren, New Jersey 07059, made application to the 
Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
2, 5-Dimethoxyamphetamine (7396)...........  I                          
Amphetamine (1100).........................  II                         
------------------------------------------------------------------------

    A registered manufacturer filed an objection dated October 16, 
1995, to the registration of Celgene Corporation as a bulk manufacturer 
of amphetamine stating that they do not believe there is need for 
another manufacturer. They also requested a hearing if DEA would not 
deny the application. Under Title 21, Code of Federal Regulations, 
Section 1301.43(b), DEA is not required to limit the number of 
manufacturers solely because a smaller number is capable of producing 
an adequate supply provided effective controls against diversion are 
maintained. DEA has conducted an investigation of Celgene Corporation, 
and determined that effective controls against diversion will be 
maintained. The request for a hearing is not valid since it was 
received after July 20, 1995, the date Title 21, Code of Federal 
Regulations, Section 1304.43(a) was amended to eliminate the third-
party manufacturer hearing requirement for objections to certain bulk 
manufacturers.
    Therefore, pursuant to section 303 of the Comprehensive Drug Abuse 
Prevention and Control Act of 1970 and Title 21, Code of Federal 
Regulations, Section 1301.54(e), Deputy Assistant Administrator, Office 
of Diversion Control, hereby orders that the application submitted by 
the above firm for registration as a bulk manufacturer of the basic 
classes of controlled substances listed above is granted.

    Dated: December 15, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-2315 Filed 2-2-96; 8:45 am]
BILLING CODE 4410-09-M